Skip to Content

CREST-2

CREST-2: The Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis (CREST-2) Study

Objective

CREST-2 is a study for people who have narrowing in their carotid artery without stroke warning signs caused by that artery, such as small strokes or temporary strokes called TIAs, temporary paralysis or numbness on one side of the body, temporary slurring of speech, or other temporary brain symptoms.

CREST‐2 is comparing intensive medical management alone to intensive medical management used in combination with a procedure involving reopening the carotid artery in the neck for treatment of plaque buildup to prevent stroke from the narrowing of the carotid artery.

If you would like to learn more about this trial, please contact Kerri Kanegae, CRC at 425.635.6081 or Kim Glorieux, CRC at 425.635.6082.

Principal Investigator(s)
Kathleen Gibson, MD

Clinical Trial Categories

  • Vascular / Surgical
  • Cardiovascular
  • Neuroscience
Contact
Research Study Staff at 425-688-5407

Location

  • Overlake Medical Center
    1035 116th Ave. NE
    Bellevue, WA 98004
    Main: 425-688-5000